YCYing-Sheng Cheng

Ying-Sheng Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying-Sheng Cheng has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A GPS Map for Pulmonary Hypertension: A Review of Imaging Modalities

    by Jinghui Li, Ashley Lee, Yingsheng Cheng

    Pulmonary hypertension (PH) is a lethal disease with a prevalence of 10-20 % in the general population. The current gold standard diagnosis approach is right heart catheterization, directly detecting pulmonary artery pressure. Imaging for PH patients plays an important role in the etiological diagnosis and evaluation of right heart (RV) function, which is a key determinant of morbidity and mortality in PH patients. Currently, echocardiography is the first-line imaging modality for screening PH and evaluating RV function. CMRI is the gold standard method to evaluate RV function. MDCT, radionuclide ventriculography and pulmonary angiography are mostly used in the differential diagnosis of the cause of PH. In this review article, we also mention several newly studied imaging modalities, such as three-dimensional echocardiography, intravascular ultrasound (IVUS) and optical coherence tomography (OCT), which showed promise for early diagnosis of PH.


  • 13-Year Follow-Up of a Prospective Comparison of the Long-Term Clinical Efficacy of Temporary Self-Expanding Metallic Stents and Pneumatic Dilatation for the Treatment of Achalasia in 120 Patients

    by Yong-Dong Li, Guang-Yu Tang, Ying-Sheng Cheng, Ni-Wei Chen, Wei-Xiong Chen, Jun-Gong Zhao

    OBJECTIVE. The purpose of this article is to compare the efficacy of self-expanding metallic stents and pneumatic dilation for the long-term clinical treatment of achalasia. SUBJECTS AND METHODS. Patients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3–5, 5–8, 8–10, and more than 10 years after surgery. RESULTS. Pneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D was also longer than that in groups A, B, and C. CONCLUSION. A temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or self-expanding metallic stents with diameters of 20 or 25 mm.


  • Temporary self-expanding metallic stents and pneumatic dilation for the treatment of achalasia: a prospective study with a long-term follow-up

    by Y.-D. Li, Y.-S. Cheng, M.-H. Li, N.-W. Chen, W.-X. Chen, J.-G. Zhao

    The present study compares the efficacy of a self-expanding metallic stent (SEMS, diameter of 30 mm) and pneumatic dilation for the long-term clinical treatment of achalasia. A total of 155 patients diagnosed with achalasia were allocated for pneumatic dilation (n= 80, group A) or a temporary, 30-mm diameter SEMS (n= 75, group B). The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4-5 days after placement. Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up observations were performed at 6 months and at 1, 3-5, 5-8, 8-10, and >10 years, postoperatively. Pneumatic dilation and stent placement were technically successful in all of the patients. There were no significant differences in technique success, 30-day mortality, or complications between the two groups. The clinical remission rate in group A was significantly lower than that in group B at 1, 1-3, 3-5, 5-8 and, >10 years (P < 0.05), while the cumulative clinical failure rate in group A (66%, 53/80) was higher than that in group B (92%, 6/75). The mean primary patency in group B was significantly longer than that in group A (4.2 vs 2.1 years, respectively; P < 0.001). A temporary, 30-mm diameter SEMS was associated with a better long-term clinical efficacy in the treatment of patients with achalasia as compared with treatment with pneumatic dilation.


  • Open Access

    Temporary self-expanding metallic stents for achalasia: A prospective study with a long-term follow-up

    by Ying-Sheng Cheng

    To compare the efficacy of self-expanding metallic stents (SEMSs) for the long-term clinical treatment of achalasia. Ninety achalasic patients were treated with a temporary SEMS with a diameter of 20 mm (n = 30, group A), 25 mm (n = 30, group B) or 30 mm (n = 30, group C). Data on clinical symptoms, complications and treatment outcomes were collected, and follow-up was made at 6 mo and at 1, 3-5, 5-8, 8-10 and > 10 years, postoperatively. Stent placement was successful in all patients. Although chest pain occurrence was high, stent migration was less in group C than in groups A and B. The clinical remission rate at 5-8, 8-10 and > 10 years in group C was higher than that in the other two groups. The treatment failure rate was lower in group C (13%) than in groups A (53%) and B (27%). SEMSs in group C resulted in reduced dysphagia scores and lowered esophageal sphincter pressures, as well as normal levels of barium height and width during all the follow-up time periods. Conversely, these parameters increased over time in groups A and B. The primary patency in group C was longer than in groups A and B. A temporary SEMS with a diameter of 30 mm is associated with a superior long-term clinical efficacy in the treatment of achalasia compared with a SEMS with a diameter of 20 mm or 25 mm.


  • Open Access

    Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience

    by Jun-Gong Zhao, Yong-Dong Li, Ying-Sheng Cheng, Ming-Hua Li, Ni-Wei Chen, Wei-Xiong Chen, Ke-Zhong Shang

    To prospectively evaluate the long-term clinical safety and efficacy of a newly designed self-expanding metallic stent (SEMS) in the treatment of patients with achalasia. Seventy-five patients with achalasia were treated with a temporary SEMS with a 30-mm diameter. The SEMSs were placed under fluoroscopic guidance and removed by gastroscopy 4–5 days after stent placement. Follow-up data focused on dysphagia score, technique and clinical success, clinical remissions and failures, and complications and was performed at 6 months, 1 year, and within 3 to 5 years, 5 to 8 years, 8 to 10 years, and >10 years postoperatively. Stent placement was technically successful in all patients. Complications included stent migration (n = 4, 5.33%), chest pain (n = 28, 38.7%), reflux (n = 15, 20%), and bleeding (n = 9, 12%). No perforation or 30-day mortality occurred. Clinical success was achieved in all patients 1 month after stent removal. The overall remission rates at 6 months, 1, 1–3, 3–5, 5–8, 8–10, and >10 year follow-up periods were 100%, 96%, 93.9%, 90.9%, 100%, 100%, and 83.3%, respectively. Stent treatment failed in six patients, and the overall remission rate in our series was 92%. The median and mean primary patencies were 2.8 ± 0.28 years (95% CI: 2.25–3.35) and 4.28 ± 0.40 years (95% CI: 3.51–5.05), respectively. The use of temporary SEMSs with 30-mm diameter proved to be a safe and effective approach for managing achalasia with a long-term satisfactory clinical remission rate.


  • Open Access

    Optimization of contrast agents for small intestine computed tomography enteroclysis

    by Fu-Zhen Song, Ying-Sheng Cheng, Yue-Qi Zhu, Pei-Rong Zhao, Jun-Gong Zhao, Bing-Hui Zhao

    目的: 评价何种对比剂在小肠CT造影时能充分充盈扩张肠管、不易形成伪影, 在显示小肠肠腔、肠壁方面最佳. 方法: 8条健康成年毕格犬麻醉后, 插管至十二指肠屈氏韧带以下, 静脉注射654-2, 经导管注入不同的对比剂: 纯水、纯牛奶、10 mL/L泛影葡胺后行MSCT扫描, 平扫结束后行增强扫描. 通过横断面及多平面重建, 测量肠腔宽度、肠壁厚度, 对各组测量及评价结果进行统计学分析. 同时测量平扫、增强后20 s、30 s、40 s、50 s 时肠壁的CT值, 测量计算肠腔与肠壁对比程度最好时, 肠腔与肠壁密度的CT值差值范围. 结果: 在肠腔宽度的比较上, 纯牛奶组与纯水组、泛影葡胺组的差异有统计学意义(F = 28.115, P结论: 纯牛奶是较理想的小肠CT造影对比剂, 能够充分充盈扩张肠腔, 同时能够较好的显示肠腔、肠壁的情况.

  • Open Access

    Complications of stent placement for benign stricture of gastrointestinal tract

    by Ying-Sheng Cheng, Ming-Hua Li, Wei-Xiong Chen, Ni-Wei Chen, Qi-Xin Zhuang, Ke-Zhong Shang

    AIM: To observe the frequent complications of stent placement for stricture of the gastrointestinal tract and to find proper treatment. METHODS: A total number of 140 stents were inserted in 138 patients with benign stricture of the gastrointestinal tract. The procedure was completed under fluoroscopy in all of the patients. RESULTS: Stents were successfully placed in all the 138 patients. Pains occurred in 23 patients (16.7%), slight or dull pains were found in 21 patients and severe chest pain in 2 respectively. For the former type of pain, the patients received only analgesia or even no treatment, while peridural anesthesics was conducted for the latter condition. Reflux occurred in 16 of these patients (11.6%) after stent placement. It was managed by common antireflux procedures. Gastrointestinal bleeding occurred in 13 patients (9.4%), and was treated by hemostat. Restenosis of the gastrointestinal tract occurred in 8 patients (5.8%), and was apparently associated with hyperplasia of granulation tissue. In 2 patients, the second stent was placed under X-ray guidance. The granulation tissue was removed by cauterization through hot-node therapy under gastroscope guidance in 3 patients, and surgical reconstruction was performed in another 3 patients. Stent migration occurred in 5 patients (3.6%), and were extracted with the aid of a gastroscope. Food-bolus obstruction was encountered in 2 patients (1.4%) and was treated by endoscope removal. No perforation occurred in all patients. CONCLUSION: Frequent complications after stent placement for benign stricture of the gastrointestinal tract include pain, reflux, bleeding, restenosis, stent migration and food-bolus obstruction. They can be treated by drugs, the second stent placement or gastroscopic procedures depend on the specific condition.


  • Open Access

    Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract

    by Ying-Sheng Cheng, Ming-Hua Li, Wei-Xiong Chen, Ni-Wei Chen, Qi-Xin Zhuang, Ke-Zhong Shang

    Comparative observation on different intervention procedures in benign stricture of gastrointestinal tract


  • Open Access

    Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up

    by Ying-Sheng Cheng, Ming-Hua Li, Wei-Xiong Chen, Ni-Wei Chen, Qi-Xin Zhuang, Ke-Zhong Shang

    Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up